Applying Recombinant Antibody Engineering to Further Immunoassay Development

Recombinant antibody technology allows diagnostic and immunoassay developers to obtain highly reliable and tailored antibodies, enabling superior performance for the entire lifespan of a diagnostic product.

In this presentation, Business Development Manager Alex Scott discusses how antibody engineering allows assay developers to custom design antibodies to improve their performance in rapid diagnostic tests. Topics include:

  • Generating precisely defined controls in unique formats, including IgG, IgA and IgM, for serology rapid tests in the infectious disease field
  • Streamlining immobilization and conjugation chemistries with standardized Fc domains
  • Creating non-natural antibody scaffolds for higher avidity detection and capture
  • Leveraging other novel antibody formats, including chimeric antibodies, fragments and bispecifics


Please enter your contact information below to view the video.

Absolute Antibody may use your contact information to send you information about the products and services from our Absolute Biotech family of brands. You can unsubscribe at any time by clicking the “unsubscribe” link included in every marketing email. For more information, please see our privacy policy here.